Oaktree Acquisition Corp. III Life Sciences (OACC) stock
OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.71−0.02 (-0.19%)
Close on Nov 20, 2026Market cap $263.28MP/E –Yield –
Oaktree Acquisition Corp. III Life Sciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?